-
Abstract Number: OC 20.5
Haemophilia-mediated bleeding induces red pulp macrophage expansion
-
Abstract Number: OC 78.4
Haemorrhagic sub-phenotypes in hereditary haemorrhagic telangiectasia are associated with high impact DNA variants in platelet/coagulation genes responsible for general population bleeding disorders
-
Abstract Number: PB0086
Haemostatic differences between SARS-CoV-2 PCR-positive and -negative patients at the time of hospital admission
-
Abstract Number: PB1333
Hand grip strength and risk of incident venous thromboembolism: The Tromsø Study
-
Abstract Number: VPB0722
Health education needs in hematological orphan diseases for professionals, sick people and caregivers in Ibagué, Tolima
-
Abstract Number: PB1327
Health-Related Quality of Life and physical capacity in patients with residual perfusion defects after pulmonary embolism
-
Abstract Number: PB0651
Health-Related Quality-of-Lives in Hemophilia A patients on prophylactic therapy of Emicizumab (Hemlibra)
-
Abstract Number: PB1387
Heavy menstrual bleeding from anticoagulation therapy significantly impacts on women’s quality of life – findings from the PERIOD programme of work
-
Abstract Number: VPB0760
Heightened Procoagulation After Thromboprophylaxis Completion inOrthopaedic Surgery Patients with Metastatic Bone Disease: Outcome of A Pilot Study
-
Abstract Number: PB0077
Hematologic Findings and Complications of SARS-COV-2 in Children and Young Adults
-
Abstract Number: VPB0723
Hematological orphan diseases and health literacy in sick people: State of the art
-
Abstract Number: VPB0250
Heme regulates inflammatory signaling pathways in human choroid plexus epithelial cells after preterm intraventricular hemorrhage
-
Abstract Number: PB0704
Hemizygous FGG p.Ala108Gly in a hypofibrinogenemic patient with a heterozygous 14.8 Mb deletion encompassing the entire fibrinogen gene cluster
-
Abstract Number: VPB0835
Hemoglobin concentration is a determinate of plasma VWF and FVIII levels
-
Abstract Number: PB0663
Hemophilia Joint Health Score (HJHS) and Hemophilia Early Arthropathy Detection with Ultrasound (HEAD-US) score in patients with hemophilia: experience from a single comprehensive care center
-
Abstract Number: PB1135
Hemophilia Registry in a province in nothern Spain
-
Abstract Number: OC 16.2
Hemorrhage risk in direct oral anticoagulant users receiving tamoxifen for breast cancer versus aromatase inhibitors: The STOP-Bleed Cancer study
-
Abstract Number: PB0323
Hemorrhagic clinic in an immune-mediated and prothrombotic entity: heparin-induced thrombocytopenia (HIT). Case report
-
Abstract Number: LB 02.2
Hemorrhagic, Coagulopathic, and Thrombotic (HECTOR) Complications Among Critically-Ill Patients with COVID-19: An International COVID-19 Critical Care Consortium Study
-
Abstract Number: PB1275
Hemostasis after vessel injury occurs under high shear conditions
-
Abstract Number: PB1023
Hemostasis in Yellow Fever: results from the 2018 outbreak in Brazil
-
Abstract Number: VPB0107
Hemostasis markers determining unfavorable outcome in covid-induced coagulopathy
-
Abstract Number: PB0808
Hemostatic response to exercise training in patients with continuous-flow left ventricular assist device
-
Abstract Number: PB0819
Hemostatic Response to Subcutaneous versus Intranasal Desmopressin in Patients with Von Willebrand Disease (VWD)
-
Abstract Number: OC 21.2
Hemostatic results for up to 6 years following treatment with valoctocogene roxaparvovec, an AAV5-hFVIII-SQ gene therapy for severe hemophilia A
-
Abstract Number: PB0377
Heparin and heparin proteoglycan-mimetics activate platelets via PEAR1 and PI3Kbeta
-
Abstract Number: PB0034
Heparin Induced Thrombocytopenia Before and During COVID-19 Pandemia in Iran
-
Abstract Number: VPB1119
Heparin monitoring during ECMO: Anti-Xa assay with and without dextran
-
Abstract Number: PB0325
Heparin-induced thrombocytopenia (HIT) in a COVID-19 patient on extracorporeal membrane oxygenation (ECMO) support: case report experience with rivaroxaban
-
Abstract Number: PB0782
Hepsin is a risk factor for thrombosis and metastasis in localized colorectal cancer patients
-
Abstract Number: VPB0720
Hereditary Severe Factor XIII Deficiency in Northern region of Turkey
-
Abstract Number: PB1232
Hermansky-Pudlak syndrome: Identification of novel variants in the genes HPS3, HPS5, and DTNBP1 (HPS-7) and analysis of lymphocyte cytotoxicity for the HPS-7 patient
-
Abstract Number: PB1247
High bleeding rates in delta-storage pool disease
-
Abstract Number: PO0063
High factor VIII levels and recurrent thromboembolism in patients with and without inflammatory bowel disease: a retrospective comparative study
-
Abstract Number: VPB1222
High Frequency of Bone Marrow Evaluations but Low Diagnostic Yield in Relapsed or Refractory Immune Thrombocytopenia
-
Abstract Number: PB0770
High levels of TLT-1+, but not Gp1b+, Microparticles Are Indicative of Poor Outcomes in Acute Respiratory Distress Syndrome
-
Abstract Number: PB0075
High plasma levels of activated factor VII-antithrombin complex indicate increased tissue factor expression/activation in patients with COVID-19.
-
Abstract Number: OC 44.4
High plasma levels of C1 esterase inhibitor reduce intrinsic pathway-initiated coagulation and are associated with reduced future risk of venous thromboembolism
-
Abstract Number: PB0178
High plasma levels of IgG4 anti-FVIII is the hallmark of immune tolerance failure in patients with hereditary hemophilia A: results from the BrazIT Study
-
Abstract Number: PB0017
High prevalence and wide variety of clonal haematopoiesis-driver mutations in patients with severe aortic valve stenosis undergoing transcatheter aortic valve replacement
-
Abstract Number: PB0095
High Prevalence of Anti-PF4 Antibodies Among Hospitalized Pediatric COVID-19 Patients and The Impact on Morbidity and Mortality
-
Abstract Number: VPB1428
High Prevalence of Non RhD Antibodies Among Antenatal Women attending Tertiary care Centre Hyderabad Pakistan
-
Abstract Number: OC 08.1
High rate of recurrent thrombosis in children with unprovoked venous thromboembolism
-
Abstract Number: OC 44.5
High α2-macroglobulin levels are a risk factor for cardiovascular events
-
Abstract Number: PB0849
High-Throughput Screening to Identify Novel Small-Molecule Inhibitors of Clot Retraction
-
Abstract Number: VPB1347
Higher In-hospital Mortality of Cancer-Associated Pulmonary Embolism: Findings from the CURES Registry
-
Abstract Number: OC 41.3
Histidine-rich glycoprotein binds GPIIb/IIIa and attenuates platelet aggregation
-
Abstract Number: PB0873
Histology of Shear-Induced Platelet Aggregated (SIPA) Thrombus Formed in vitro
-
Abstract Number: PB1040
Histone-3 plasma levels as a potential pre-thrombotic marker up regulated in patients with digestive carcinomatosis
-
Abstract Number: OC 78.3
HMB-001 – a novel bispecific antibody accumulating and targeting endogenous FVIIa to activated platelets for subcutaneous prophylaxis in multiple bleeding disorders including Glanzmann Thrombasthenia
-
Abstract Number: VPB0964
Homocysteine as an independent thrombosis risk factor
-
Abstract Number: OC 69.3
Homology Directed Repair Edited Megakaryocytes For Rapid Screening of Platelet Gene Variant Functions
-
Abstract Number: VPB1426
How can changes in secondary haemostasis be useful for the management of pregnancy ?
-
Abstract Number: PB0814
How do laboratories perform von Willebrand disease (VWD) diagnostics?
-
Abstract Number: PB0391
Human platelets do not express a functional FcERI receptor on their surface
-
Abstract Number: OC 36.2
Hydrophobic patch (PLVIVG 1481-1486) in FV-Short crucial for its synergistic TFPI-cofactor activity with protein S and the formation of a FXa-inhibitory complex comprising FV-Short, protein S and TFPI
-
Abstract Number: PB0411
Hydroxychloroquine as an adjunct treatment for patients with triple positive thrombotic antiphospholipid syndrome- a single centre experience
-
Abstract Number: VPB1424
Hypercoagulability and Inflammatory Markers in a Case of Congenital TTP Complicated by Fetal Demise
-
Abstract Number: PB0594
Hypercoagulability in COVID-19 and its putative association with the downregulation of protein C signalling
-
Abstract Number: PB0060
Hypercoagulability in COVID-19: Is there an Antiphospholipid Syndrome?
-
Abstract Number: VPB0491
Hyperfibrinolysis Drives Instabilities in Trauma Induced Coagulopathy
-
Abstract Number: PB1226
Hyperglycaemia enhances platelet degranulation and microparticle shedding: a novel mechanism underlying thrombotic complications in diabetes patients.
-
Abstract Number: OC 33.2
Hyperinflammatory state and death in patients affected by COVID-19: role of vaccines.
-
Abstract Number: PB0087
Hyperresponsive platelets and a reduced platelet granule release capacity is associated with severity of COVID-19 symptoms and with increased mortality.
-
Abstract Number: PB0627
Hypofibrinolysis in patients with aortic stenosis is driven by overexpression of plasminogen activator inhibitor type 1 (PAI- 1) associated with elevated oxidized lipoproteins
-
Abstract Number: PB0555
Hypoplasminogenemia: an International retroSpecTive and prOspective cohoRt studY (HISTORY): the international registry of patients with plasminogen deficiency
-
Abstract Number: PB1041
Hypoxia increases coagulation which is more pronounced in women but is counterbalanced by a decreased platelet reactivity
-
Abstract Number: OC 05.3
Hypoxia promotes metabolic and functional platelet exhaustion in critically ill COVID-19 patients
ISTH 2022 Congress
July 9-13, 2022. London, England, UK.